세계의 엑소좀 시장 - 규모, 점유율, 성장 분석 : 제품별, 워크플로우별, 용도별, 최종용도별, 지역별 산업 예측(2024-2031년)

Global Exosomes Market size was valued at USD 250.8 million in 2022 and is poised to grow from USD 325.79 million in 2023 to USD 2641.25 million by 2031, growing at a CAGR of 29.9% during the forecast period (2024-2031).

Extracellular vesicles (EVs), commonly known as exosomes, are ubiquitous cell communication agents found across various bodily fluids such as serum, urine, and breast milk. Their ability to transport proteins and genetic material positions them as crucial players in diagnostics and therapeutics, particularly in the face of rising cancer incidents. Key drivers for the EV market include advancements in exosome separation technologies, increased research funding, and the growing incidence of diseases like cancer-projected to account for nearly 10 million deaths in 2023. The pandemic has also catalyzed innovations, exemplified by the development of exosome-based COVID-19 vaccines. These vesicles promise significant therapeutic benefits, including drug delivery efficiency and low toxicity, thereby shaping a burgeoning market for disease detection and innovative treatments in the coming years.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Exosomes market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Exosomes Market Segmental Analysis

Global Exosomes Market is segmented by product, workflow, application, end-use and region. Based on product, the market is segmented into kits & reagents, instruments and services. Based on workflow, the market is segmented into isolation methods and downstream analysis. Based on application, the market is segmented into cancer, cardiovascular diseases (CVD), neurodegenerative diseases, infectious diseases and others. Based on end-use, the market is segmented into academic & research institutes, pharmaceutical & biotechnology companies and hospitals & clinical testing laboratories. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Exosomes Market

The growth of the global exosomes market is largely driven by the rising investments in pharmaceutical research and development (R&D) along with life sciences initiatives. Pharmaceutical, biopharmaceutical, and medical device companies allocate substantial resources towards the advancement of innovative drugs and technologies. This investment in R&D is critical for the pharmaceutical industry, which prioritizes the delivery of high-quality, cutting-edge products. Recent trends indicate that major pharmaceutical firms are improving their R&D efficiency through substantial long-term funding and collaborative research ventures, ultimately fueling advancements in exosome technologies and applications across various therapeutic areas.

Restraints in the Global Exosomes Market

The global exosomes market faces significant constraints primarily due to the absence of established standard protocols for exosome development and production. As exosome research remains in its nascent stages, scientists often resort to employing novel techniques and methodologies with little hesitation. This lack of standardization not only presents challenges during the creation of exosomes but also complicates their research, development, and manufacturing processes. While exosomes derived from mesenchymal stem cells (MSCs) are garnering interest for their role as intercellular messengers, there is an urgent need for industry leaders to innovate effective harvesting techniques and develop comprehensive standards for exosome characterization and purification to advance their application in areas like vaccine development, cancer diagnostics, and gene therapy.

Market Trends of the Global Exosomes Market

The Global Exosomes market is experiencing a significant upward trend driven by the increasing recognition of exosomes as a versatile treatment platform for various conditions, notably including COVID-19. Their unique ability to deliver therapeutic cargo while minimizing immune rejection positions exosomes as a promising cell-free therapeutic option for numerous diseases and tissue regeneration applications. The growing interest in exosomal therapy, particularly for respiratory viral infections like SARS-CoV-2, underscores the potential of stem cell-derived exosomes to leverage anti-inflammatory and regenerative properties. This trend indicates a robust future for exosome-based treatments as they gain acceptance in the medical community.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Case Studies

Global Exosomes Market Size by Product & Service & CAGR (2024-2031)

• Market Overview
• Kits & Reagents
  • Isolation Kits
  • Purification Kits
  • Detection Kits
• Instruments
  • Ultracentrifuges
  • Flow Cytometers
  • Others
• Services
  • Exosome Isolation Services
  • Exosome Characterization Services
  • Exosome Profiling Services

Global Exosomes Market Size by Workflow & CAGR (2024-2031)

• Market Overview
• Isolation Methods
  • Ultracentrifugation
  • Immunocapture On Beads
  • Precipitation
  • Filtration
  • Others
• Downstream Analysis
  • Flow Cytometry
  • Mass Spectrometry
  • Next-Generation Sequencing (NGS)
  • Western Blotting
  • Others

Global Exosomes Market Size by Application & CAGR (2024-2031)

• Market Overview
• Cancer
  • Lung Cancer
  • Breast Cancer
  • Prostate Cancer
  • Colorectal Cancer
  • Others
• Cardiovascular Diseases (CVD)
• Neurodegenerative Diseases
• Infectious Diseases
• Others

Global Exosomes Market Size by End-Use & CAGR (2024-2031)

• Market Overview
• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Hospitals & Clinical Testing Laboratories

Global Exosomes Market Size & CAGR (2024-2031)

• North America (Product & Service, Workflow, Application, End-Use)
  • USA
  • Canada
• Europe (Product & Service, Workflow, Application, End-Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product & Service, Workflow, Application, End-Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product & Service, Workflow, Application, End-Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product & Service, Workflow, Application, End-Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• QIAGEN (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Takara Bio Company (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Illumina, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Codiak Biosciences (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Exosome Diagnostics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Evox Therapeutics (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ExCoBio Inc. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories Ltd. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoSomix, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• System Biosciences (SBI) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lonza Group (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Miltenyi Biotec (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Norgen Biotek Corp. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AMS Biotechnology (AMSBIO) (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Creative Biolabs (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Capricor Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Aegle Therapeutics (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anjarium Biosciences (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations